First Trust Advisors LP Makes New Investment in Trupanion, Inc. (NASDAQ:TRUP)

First Trust Advisors LP purchased a new position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 146,945 shares of the financial services provider's stock, valued at approximately $7,083,000. First Trust Advisors LP owned 0.35% of Trupanion as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the company. Jones Financial Companies Lllp grew its position in Trupanion by 71.7% in the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider's stock valued at $27,000 after purchasing an additional 238 shares during the period. GAMMA Investing LLC lifted its position in Trupanion by 18.5% in the 4th quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider's stock valued at $82,000 after acquiring an additional 267 shares in the last quarter. SBI Securities Co. Ltd. acquired a new position in Trupanion during the 4th quarter valued at about $25,000. Swiss National Bank increased its holdings in Trupanion by 1.1% during the 4th quarter. Swiss National Bank now owns 66,310 shares of the financial services provider's stock worth $3,196,000 after purchasing an additional 700 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Trupanion by 2.7% in the third quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider's stock worth $1,189,000 after purchasing an additional 738 shares during the last quarter.

Trupanion Stock Performance

Shares of Trupanion stock traded up $8.56 on Friday, reaching $45.00. 1,622,126 shares of the company traded hands, compared to its average volume of 660,617. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The firm has a market capitalization of $1.91 billion, a PE ratio of -195.65, a PEG ratio of 6.02 and a beta of 1.66. The company has a 50 day moving average of $35.60 and a 200 day moving average of $44.94. Trupanion, Inc. has a 52 week low of $19.69 and a 52 week high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02. The firm had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business's revenue was up 11.7% on a year-over-year basis. During the same period in the previous year, the company posted ($0.16) earnings per share. Equities analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insiders Place Their Bets

In related news, SVP Emily Dreyer sold 14,025 shares of the business's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $32.41, for a total transaction of $454,550.25. Following the sale, the senior vice president now directly owns 27,645 shares in the company, valued at approximately $895,974.45. The trade was a 33.66 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Margaret Tooth sold 2,294 shares of the firm's stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total value of $72,008.66. Following the completion of the transaction, the chief executive officer now owns 118,784 shares of the company's stock, valued at approximately $3,728,629.76. This represents a 1.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,792 shares of company stock worth $1,122,802 over the last quarter. 5.50% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on TRUP. Piper Sandler lowered their price target on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research report on Thursday, February 20th. Stifel Nicolaus dropped their price target on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research report on Thursday, February 20th. Finally, Lake Street Capital reduced their price objective on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research report on Friday. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $48.83.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.